Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Oral Diseases|August 8, 2002
The epidemiology and pathophysiology of HIV--as seen by a South AfricanL G BekkerSouth African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 6, 2014
Isoniazid preventive therapy for tuberculosis in South Africa: an assessment of the local evidence baseR Wood, L-G BekkerSouth African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 4, 2015
Pre-exposure prophylaxis for South African adolescents: What evidence?L-G Bekker, K Gill, M WallaceNovartis Foundation Symposium|February 9, 1999
Recombinant interleukin 2 adjunctive therapy in multidrug-resistant tuberculosisB Johnson, L G Bekker, S Ress, et al.The Journal of Infectious Diseases|August 11, 1998
Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosisL G Bekker, G Maartens, L Steyn, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 18, 2010
Earlier HIV diagnosis--are mobile services the answer?N van Schaik, K Kranzer, R Wood, et al.The Journal of Infectious Diseases|March 18, 2000
Thalidomide-induced antigen-specific immune stimulation in patients with human immunodeficiency virus type 1 and tuberculosisL G Bekker, P Haslett, G Maartens, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 6, 2016
The mass miniature chest radiography programme in Cape Town, South Africa, 1948 - 1994: The impact of active tuberculosis case findingS M Hermans, J R Andrews, L-G Bekker, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 20, 2012
Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatmentK Middelkoop, L-G Bekker, E Shashkina, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
TNF-alpha controls intracellular mycobacterial growth by both inducible nitric oxide synthase-dependent and inducible nitric oxide synthase-independent pathwaysL G Bekker, S Freeman, P J Murray, et al.Pageof 5